search
Back to results

Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy (CiPNT/SSI)

Primary Purpose

Surgical Site Infection, Length of Stay, Seroma

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Closed incision negative pressure therapy versus standard dressing after emergency abdominal laparotomies
Sponsored by
University Hospital, Geneva
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Surgical Site Infection focused on measuring pNPWT, PREVENA, SSI, morbidity, dehiscence

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Adult patient
  • ≥10cm emergency median laparotomy
  • Abdominal wall and skin closure in first intent
  • Septic peritoneal cavity (purulent and/or fecaloid free liquid and/or abscess)
  • Informed written consent

Exclusion Criteria:

  • No abdominal wound closure in first intent
  • Allergy or hypersensitivity to silver
  • Application of a mesh for abdominal wall closure
  • Patients under corticosteroids or other immunosuppressive treatment.
  • Women who are pregnant or breast-feeding.
  • Intention to become pregnant during the course of the study.
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant.
  • Previous enrolment in the current study.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    Active Comparator

    Arm Label

    PREVENA (CiPNT)

    Simple dressing

    Arm Description

    Target population is every patient undergoing a laparotomic procedure and responding to inclusion criteria marked in paragraph 3.8 (see forward) A member of the medical surgery team should apply all parts just after the surgical procedure. A medical member (nurse specialist in wound care) of the surgical team removes the dressing. All other manipulations of the therapy unit, the connector and the cartridge can be carried out by any nurse practitioner in hospital or extra hospital environment but must warn the investigators. The aspiration will be stopped 24 hours before and the dressing is removed by a nurse at home or in the hospital. The specialized nurse who will take a photo and assess the condition of the wound in the treatment room. One of the investigators, non-operators, who will also assess the condition of the wound by photo.

    Simple dressing; standard, waterproof dressing applied to wound

    Outcomes

    Primary Outcome Measures

    To determine if the use of prophylactic negative-pressure wound therapy (Prevena) reduces the incidence of superficial surgical site infection after emergency laparotomy in patients at high-risk for SSI
    Any SSI may cause redness, delayed healing, fever, pain, tenderness, warmth, or swelling. Superficial site infection will be assessed by Wound Classification System Using the American College of Surgeons National Surgical Quality Improvement Program ACS-NSQIP : Clean; these are uninfected operative wounds in which no inflammation. Clean/contaminated; These are operative wounds in which the respiratory, alimentary, genital, or urinary tract is entered Under controlled conditions and without unusual contamination. Contaminated; These include open, fresh, accidental wounds, operations with major breaks in sterile technique or gross spillage from the gastrointestinal tract, and incisions in which acute, non-purulent inflammation is encountered. Dirty ; These include old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera.

    Secondary Outcome Measures

    Length of stay (LOS) in days.
    LOS is defined as days from operation to discharge; 30d LOS is defined as the index LOS plus all readmission days within 30d related to any wound complications.
    30-day Return to Operating Room (ROR)
    Reoperation for wound complication within 30 days involving incision and drainage in the operating room; opening the skin to drain a superficial soft tissue infection at bedside or in the office is not considered reoperation.
    Incidence rates of wound complications
    Individual rates of the incidence of each of the following: dehiscence (skin or fascia), seroma, lymph leak, infection, hematoma, ischemia and necrosis.

    Full Information

    First Posted
    July 16, 2020
    Last Updated
    April 27, 2021
    Sponsor
    University Hospital, Geneva
    Collaborators
    Meyer Jeremy. PhD. Co-investigator. University Hospital, Geneva., Peloso Andrea. PhD. Co-investigator. University Hospital, Geneva., Ris Frederic. P.D. Clinical Professor. University Hospital, Geneva., Toso Christian. PhD. Head of visceral surgery. University Hospital, Geneva., Buchs C. Nicolas. P.D. Director of the project. University Hospital, Geneva.
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT04496180
    Brief Title
    Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy
    Acronym
    CiPNT/SSI
    Official Title
    Standard Wound Dressing Versus Prophylactic Negative-pressure Wound Therapy After Emergency Laparotomy: a Randomized Controlled Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    April 2021
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    September 1, 2021 (Anticipated)
    Primary Completion Date
    September 1, 2023 (Anticipated)
    Study Completion Date
    September 1, 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    University Hospital, Geneva
    Collaborators
    Meyer Jeremy. PhD. Co-investigator. University Hospital, Geneva., Peloso Andrea. PhD. Co-investigator. University Hospital, Geneva., Ris Frederic. P.D. Clinical Professor. University Hospital, Geneva., Toso Christian. PhD. Head of visceral surgery. University Hospital, Geneva., Buchs C. Nicolas. P.D. Director of the project. University Hospital, Geneva.

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    Yes
    Data Monitoring Committee
    No

    5. Study Description

    Brief Summary
    Post-operative wound complications in abdominal surgery have a major impact on patient outcomes and the real impact of Closed incision negative pressure therapy (CINVt) is not clear in the literature moreover concerning its potential economic benefits The hypothesis of this study is that CINPt has the potential to reduce Surgical Site Infections. Secondly the investigators aim to study the economic impact of CINPt used after abdominal emergency laparotomies.
    Detailed Description
    Emergency laparotomies lead to increased morbidity and mortality rates. In this scenario the most frequent wound occurrences are represented by wound infections, skin dehiscence or parietal hernias. Despite standard surgical aseptically technique and perioperative prevention management of infections (e.g. antibiotics), wound complications after emergency laparotomies are still an important unmet challenge. Moreover, all these complications increase the cost of care requiring new managements. CINPt has been longly used to favour the successful healing of a plethora of open wounds. In particular CINPt is based on the application of local negative pressure to the wound surface. In case of open abdomens, the procedure is performed by applying a sterile abdominal dressing, which consists of a fenestrated soft plastic non-adherent layer with enclosed central foam, which is placed on the surface of the viscera. Then, two layers of porous sponge dressings are applied over the plastic layer. Finally, a transparent adhesive is placed over the foam and the wound to seal the abdominal cavity. The entire system is then connected, by suction tubes, to a device which ubiquitously applies negative pressure (cyclically or continuously) on the surface. The fluid from the wound is collected into a container. The benefits of negative pressure wound therapy have been reported to include removal of infectious material, reduction in oedema and improved perfusion to tissue. Since few years, a new negative pressure wound therapy has been created for closed wounds to reduce time of healing and avoid wound complications.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Surgical Site Infection, Length of Stay, Seroma, Hematoma
    Keywords
    pNPWT, PREVENA, SSI, morbidity, dehiscence

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Parallel Assignment
    Model Description
    Study Type: Interventional (Clinical Trial) Estimated Enrollment: 334 Allocation: Randomized control trial Intervention Model: Parallel Assignment Intervention Model Description: 2 separate treatment arms Primary Purpose: Prevention Official Title: Standard wound dressing versus prophylactic negative-pressure wound therapy after emergency laparotomy Estimated Study Start Date: 09.2020 Estimated Primary Completion Date:09.2021 Estimated Study Completion Date: 09.2025
    Masking
    None (Open Label)
    Allocation
    Randomized
    Enrollment
    334 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    PREVENA (CiPNT)
    Arm Type
    Experimental
    Arm Description
    Target population is every patient undergoing a laparotomic procedure and responding to inclusion criteria marked in paragraph 3.8 (see forward) A member of the medical surgery team should apply all parts just after the surgical procedure. A medical member (nurse specialist in wound care) of the surgical team removes the dressing. All other manipulations of the therapy unit, the connector and the cartridge can be carried out by any nurse practitioner in hospital or extra hospital environment but must warn the investigators. The aspiration will be stopped 24 hours before and the dressing is removed by a nurse at home or in the hospital. The specialized nurse who will take a photo and assess the condition of the wound in the treatment room. One of the investigators, non-operators, who will also assess the condition of the wound by photo.
    Arm Title
    Simple dressing
    Arm Type
    Active Comparator
    Arm Description
    Simple dressing; standard, waterproof dressing applied to wound
    Intervention Type
    Device
    Intervention Name(s)
    Closed incision negative pressure therapy versus standard dressing after emergency abdominal laparotomies
    Other Intervention Name(s)
    PREVENA
    Intervention Description
    Target population is every patient undergoing a laparotomic procedure and responding to inclusion criteria marked in paragraph 3.8 (see forward) A member of the medical surgery team should apply the PREVENA just after the surgical procedure. A medical member (nurse specialist in wound care) of the surgical team removes the dressing. All other manipulations of the therapy unit, the connector and the cartridge can be carried out by any nurse practitioner in hospital or extra hospital environment but must warn the investigators. The aspiration will be stopped 24 hours before and the dressing is removed by a nurse at home or in the hospital. The specialized nurse who will take a photo and assess the condition of the wound in the treatment room. One of the investigators, non-operators, who will also assess the condition of the wound by photo.
    Primary Outcome Measure Information:
    Title
    To determine if the use of prophylactic negative-pressure wound therapy (Prevena) reduces the incidence of superficial surgical site infection after emergency laparotomy in patients at high-risk for SSI
    Description
    Any SSI may cause redness, delayed healing, fever, pain, tenderness, warmth, or swelling. Superficial site infection will be assessed by Wound Classification System Using the American College of Surgeons National Surgical Quality Improvement Program ACS-NSQIP : Clean; these are uninfected operative wounds in which no inflammation. Clean/contaminated; These are operative wounds in which the respiratory, alimentary, genital, or urinary tract is entered Under controlled conditions and without unusual contamination. Contaminated; These include open, fresh, accidental wounds, operations with major breaks in sterile technique or gross spillage from the gastrointestinal tract, and incisions in which acute, non-purulent inflammation is encountered. Dirty ; These include old traumatic wounds with retained devitalized tissue and those that involve existing clinical infection or perforated viscera.
    Time Frame
    up to 30 days post procedure
    Secondary Outcome Measure Information:
    Title
    Length of stay (LOS) in days.
    Description
    LOS is defined as days from operation to discharge; 30d LOS is defined as the index LOS plus all readmission days within 30d related to any wound complications.
    Time Frame
    30 days post procedure
    Title
    30-day Return to Operating Room (ROR)
    Description
    Reoperation for wound complication within 30 days involving incision and drainage in the operating room; opening the skin to drain a superficial soft tissue infection at bedside or in the office is not considered reoperation.
    Time Frame
    30 days post procedure
    Title
    Incidence rates of wound complications
    Description
    Individual rates of the incidence of each of the following: dehiscence (skin or fascia), seroma, lymph leak, infection, hematoma, ischemia and necrosis.
    Time Frame
    30 days post procedure
    Other Pre-specified Outcome Measures:
    Title
    A rate of parietal incisional hernia apparition after surgery
    Description
    This complication rate is multifactorial can be related to: An wall abcess Obesity with a BMI > 35 Kg/m2 medications Malnutrition Being an elderly adult Smoking Cancer a weak immune system diabetes
    Time Frame
    2 years post procedure

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: Adult patient ≥10cm emergency median laparotomy Abdominal wall and skin closure in first intent Septic peritoneal cavity (purulent and/or fecaloid free liquid and/or abscess) Informed written consent Exclusion Criteria: No abdominal wound closure in first intent Allergy or hypersensitivity to silver Application of a mesh for abdominal wall closure Patients under corticosteroids or other immunosuppressive treatment. Women who are pregnant or breast-feeding. Intention to become pregnant during the course of the study. Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant. Previous enrolment in the current study.
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Ziad Abbassi, M.D.
    Phone
    0041766931667
    Email
    Ziad.abbassi@hcuge.ch
    First Name & Middle Initial & Last Name or Official Title & Degree
    Jérémy Meyer, Ph.D.
    Phone
    0041763161984
    Email
    Jeremy.meyer@hcuge.ch

    12. IPD Sharing Statement

    Citations:
    PubMed Identifier
    22868327
    Citation
    Conde-Green A, Chung TL, Holton LH 3rd, Hui-Chou HG, Zhu Y, Wang H, Zahiri H, Singh DP. Incisional negative-pressure wound therapy versus conventional dressings following abdominal wall reconstruction: a comparative study. Ann Plast Surg. 2013 Oct;71(4):394-7. doi: 10.1097/SAP.0b013e31824c9073.
    Results Reference
    result
    PubMed Identifier
    26026135
    Citation
    Gorgulu T. A Complication of Management of Closed Incision with Negative-Pressure Wound Therapy. Aesthet Surg J. 2015 Jul;35(5):NP113-5. doi: 10.1093/asj/sju120. Epub 2015 May 29. No abstract available.
    Results Reference
    result
    PubMed Identifier
    24754343
    Citation
    Dohmen PM, Misfeld M, Borger MA, Mohr FW. Closed incision management with negative pressure wound therapy. Expert Rev Med Devices. 2014 Jul;11(4):395-402. doi: 10.1586/17434440.2014.911081. Epub 2014 Apr 22.
    Results Reference
    result
    PubMed Identifier
    24106562
    Citation
    Ingargiola MJ, Daniali LN, Lee ES. Does the application of incisional negative pressure therapy to high-risk wounds prevent surgical site complications? A systematic review. Eplasty. 2013 Sep 20;13:e49. eCollection 2013.
    Results Reference
    result
    PubMed Identifier
    21868417
    Citation
    Wilkes RP, Kilpad DV, Zhao Y, Kazala R, McNulty A. Closed incision management with negative pressure wound therapy (CIM): biomechanics. Surg Innov. 2012 Mar;19(1):67-75. doi: 10.1177/1553350611414920. Epub 2011 Aug 25.
    Results Reference
    result
    PubMed Identifier
    23231938
    Citation
    Vargo D. Negative pressure wound therapy in the prevention of wound infection in high risk abdominal wound closures. Am J Surg. 2012 Dec;204(6):1021-3; discussion 1023-4. doi: 10.1016/j.amjsurg.2012.10.004.
    Results Reference
    result
    PubMed Identifier
    27416813
    Citation
    Zaidi A, El-Masry S. Closed-incision negative-pressure therapy in high-risk general surgery patients following laparotomy: a retrospective study. Colorectal Dis. 2017 Mar;19(3):283-287. doi: 10.1111/codi.13458.
    Results Reference
    result
    PubMed Identifier
    28717587
    Citation
    Gunatilake RP, Swamy GK, Brancazio LR, Smrtka MP, Thompson JL, Gilner JB, Gray BA, Heine RP. Closed-Incision Negative-Pressure Therapy in Obese Patients Undergoing Cesarean Delivery: A Randomized Controlled Trial. AJP Rep. 2017 Jul;7(3):e151-e157. doi: 10.1055/s-0037-1603956. Epub 2017 Jul 14.
    Results Reference
    result
    PubMed Identifier
    19911098
    Citation
    Reddix RN Jr, Tyler HK, Kulp B, Webb LX. Incisional vacuum-assisted wound closure in morbidly obese patients undergoing acetabular fracture surgery. Am J Orthop (Belle Mead NJ). 2009 Sep;38(9):446-9.
    Results Reference
    result
    PubMed Identifier
    21804414
    Citation
    Stannard JP, Volgas DA, McGwin G 3rd, Stewart RL, Obremskey W, Moore T, Anglen JO. Incisional negative pressure wound therapy after high-risk lower extremity fractures. J Orthop Trauma. 2012 Jan;26(1):37-42. doi: 10.1097/BOT.0b013e318216b1e5.
    Results Reference
    result
    PubMed Identifier
    25125244
    Citation
    Pauser J, Nordmeyer M, Biber R, Jantsch J, Kopschina C, Bail HJ, Brem MH. Incisional negative pressure wound therapy after hemiarthroplasty for femoral neck fractures - reduction of wound complications. Int Wound J. 2016 Oct;13(5):663-7. doi: 10.1111/iwj.12344. Epub 2014 Aug 14.
    Results Reference
    result
    PubMed Identifier
    28705547
    Citation
    Redfern RE, Cameron-Ruetz C, O'Drobinak SK, Chen JT, Beer KJ. Closed Incision Negative Pressure Therapy Effects on Postoperative Infection and Surgical Site Complication After Total Hip and Knee Arthroplasty. J Arthroplasty. 2017 Nov;32(11):3333-3339. doi: 10.1016/j.arth.2017.06.019. Epub 2017 Jun 17.
    Results Reference
    result
    PubMed Identifier
    23539123
    Citation
    Hansen E, Durinka JB, Costanzo JA, Austin MS, Deirmengian GK. Negative pressure wound therapy is associated with resolution of incisional drainage in most wounds after hip arthroplasty. Clin Orthop Relat Res. 2013 Oct;471(10):3230-6. doi: 10.1007/s11999-013-2937-3.
    Results Reference
    result
    PubMed Identifier
    26313829
    Citation
    Semsarzadeh NN, Tadisina KK, Maddox J, Chopra K, Singh DP. Closed Incision Negative-Pressure Therapy Is Associated with Decreased Surgical-Site Infections: A Meta-Analysis. Plast Reconstr Surg. 2015 Sep;136(3):592-602. doi: 10.1097/PRS.0000000000001519.
    Results Reference
    result
    PubMed Identifier
    27844201
    Citation
    Wiegering A, Dietz UA, Corteville C, Plassmeier L, Jurowich C, Germer CT, Krajinovic K. Impact of incisional negative pressure wound therapy on perineal wound healing after abdominoperineal rectum extirpation. Int J Colorectal Dis. 2017 Feb;32(2):291-293. doi: 10.1007/s00384-016-2704-5. Epub 2016 Nov 14.
    Results Reference
    result
    PubMed Identifier
    24201395
    Citation
    Bonds AM, Novick TK, Dietert JB, Araghizadeh FY, Olson CH. Incisional negative pressure wound therapy significantly reduces surgical site infection in open colorectal surgery. Dis Colon Rectum. 2013 Dec;56(12):1403-8. doi: 10.1097/DCR.0b013e3182a39959.
    Results Reference
    result
    PubMed Identifier
    30912582
    Citation
    Webster J, Liu Z, Norman G, Dumville JC, Chiverton L, Scuffham P, Stankiewicz M, Chaboyer WP. Negative pressure wound therapy for surgical wounds healing by primary closure. Cochrane Database Syst Rev. 2019 Mar 26;3(3):CD009261. doi: 10.1002/14651858.CD009261.pub4.
    Results Reference
    result
    PubMed Identifier
    31592899
    Citation
    Zwanenburg PR, Tol BT, Obdeijn MC, Lapid O, Gans SL, Boermeester MA. Meta-analysis, Meta-regression, and GRADE Assessment of Randomized and Nonrandomized Studies of Incisional Negative Pressure Wound Therapy Versus Control Dressings for the Prevention of Postoperative Wound Complications. Ann Surg. 2020 Jul;272(1):81-91. doi: 10.1097/SLA.0000000000003644.
    Results Reference
    result
    PubMed Identifier
    25554246
    Citation
    Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA; PRISMA-P Group. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015 Jan 1;4(1):1. doi: 10.1186/2046-4053-4-1.
    Results Reference
    result

    Learn more about this trial

    Prevena to Prevent Surgical Site Infection After Emergency Abdominal Laparotomy

    We'll reach out to this number within 24 hrs